Stroke, Vol 16, 864-870, Copyright © 1985 by American Heart Association
J Weinberger, J Nieves-Rosa and G Cohen
Mongolian gerbils were treated with alpha-methyl-para-tyrosine methyl ester
(AMPT, a tyrosine hydroxylase inhibitor), in order to decrease brain levels
of catecholamines. Six hours later, unilateral ischemic stroke was induced
by ligation of the left common carotid artery. The delayed degeneration of
nerve terminals was studied sixteen hours later by measuring the
high-affinity uptake of radiolabeled transmitters by isolated synaptosomes.
Dopamine, serotonin and glutamate terminals were studied. AMPT-treated
gerbils were compared to untreated (no AMPT) animals; 220 gerbils were
studied. AMPT pretreatment (100, 250 and 400 mg/kg) produced a
dose-dependent protection of all three types of nerve terminals. In the
absence of AMPT pretreatment, the uptake of radiolabeled transmitters by
the ischemic hemisphere, expressed as a percentage of that seen in the
contralateral (unaffected) side of the brain, was as follows (mean +/-
SEM): 27.3 +/- 5.2% for dopamine terminals, 49.5 +/- 6.2% for serotonin
terminals, and 42.7 +/- 5.3% for glutamate terminals. Protection was
essentially complete at a dose of 400 mg AMPT per kg. The number of animals
with significant damage to nerve terminals was reduced from 38.5% in
untreated animals to 11.1% in animals treated with AMPT 400 mg/kg. Although
the nerve terminals were protected, gerbils still showed the behavioral
signs of unilateral stroke due to the permanent occlusion of the left
carotid. These results indicate that endogenous dopamine may play a
significant role in ischemic damage to nerve terminals in the cerebrum.
ARTICLES
Nerve terminal damage in cerebral ischemia: protective effect of alpha- methyl-para-tyrosine
This article has been cited by other articles:
![]() |
L. Y. Moy, S.-P. Wang, and P. K. Sonsalla Mitochondrial Stress-Induced Dopamine Efflux and Neuronal Damage by Malonate Involves the Dopamine Transporter J. Pharmacol. Exp. Ther., February 1, 2007; 320(2): 747 - 756. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-Y. Chen, T. Goyagi, T. J.K. Toung, J. R. Kirsch, P. D. Hurn, R. C. Koehler, and A. Bhardwaj Prolonged Opportunity for Ischemic Neuroprotection with Selective {kappa}-Opioid Receptor Agonist in Rats Stroke, May 1, 2004; 35(5): 1180 - 1185. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Goyagi, A. Bhardwaj, R. C. Koehler, R. J. Traystman, P. D. Hurn, and J. R. Kirsch Potent {sigma}1-Receptor Ligand 4-Phenyl-1-(4-Phenylbutyl) Piperidine Provides Ischemic Neuroprotection Without Altering Dopamine Accumulation In Vivo in Rats Anesth. Analg., February 1, 2003; 96(2): 532 - 538. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1985 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |